{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T17:58:24Z","timestamp":1793901504504,"version":"4.8.0"},"reference-count":123,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32CA160003"],"award-info":[{"award-number":["T32CA160003"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Clinics of North America"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.suc.2022.07.006","type":"journal-article","created":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T08:01:00Z","timestamp":1662537660000},"page":"715-737","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Abdominal Tumors"],"prefix":"10.1016","volume":"102","author":[{"given":"Jennifer T.","family":"Castle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany E.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Rodeberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Pt B","key":"10.1016\/j.suc.2022.07.006_bib1","article-title":"Childhood cancer: Survival, treatment modalities, late effects and improvements over time","volume":"71","author":"Erdmann","year":"2021","journal-title":"Cancer Epidemiol"},{"issue":"21","key":"10.1016\/j.suc.2022.07.006_bib2","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1200\/JCO.2017.77.0180","article-title":"Surveillance for Late Effects in Childhood Cancer Survivors","volume":"36","author":"Landier","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"10.1016\/j.suc.2022.07.006_bib3","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/pbc.21335","article-title":"The British Childhood Cancer Survivor Study: Objectives, methods, population structure, response rates and initial descriptive information","volume":"50","author":"Hawkins","year":"2008","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"10.1016\/j.suc.2022.07.006_bib4","first-page":"83","article-title":"Childhood and adolescent cancer statistics","volume":"64","author":"Ward","year":"2014","journal-title":"CA Cancer J Clin"},{"issue":"12","key":"10.1016\/j.suc.2022.07.006_bib6","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1182\/blood-2012-10-435719","article-title":"Treatment of acquired von Willebrand syndrome in childhood","volume":"122","author":"Callaghan","year":"2013","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.suc.2022.07.006_bib7","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1182\/blood.V58.4.665.665","article-title":"Acquired von Willebrand\u2019s disease in association with Wilm\u2019s tumor: regression following treatment","volume":"58","author":"Scott","year":"1981","journal-title":"Blood"},{"issue":"15","key":"10.1016\/j.suc.2022.07.006_bib8","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1002\/cncr.32958","article-title":"Results of Treatment for Patients With Multicentric or Bilaterally Predisposed Unilateral Wilms Tumor (AREN0534): A report from the Children\u2019s Oncology Group","volume":"126","author":"Ehrlich","year":"2020","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.suc.2022.07.006_bib9","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s11255-020-02706-5","article-title":"Preoperative Wilms tumor rupture in children","volume":"53","author":"Zhang","year":"2021","journal-title":"Int Urol Nephrol"},{"issue":"4","key":"10.1016\/j.suc.2022.07.006_bib10","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/pbc.23222","article-title":"Evaluation of diagnostic performance of CT for detection of tumor thrombus in children with Wilms tumor: a report from the Children\u2019s Oncology Group","volume":"58","author":"Khanna","year":"2012","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"10.1016\/j.suc.2022.07.006_bib11","doi-asserted-by":"crossref","first-page":"69.e1","DOI":"10.1016\/j.jpurol.2020.10.003","article-title":"Intravascular extension of Wilms tumor: Characteristics of tumor thrombus and their impact on outcomes","volume":"17","author":"Qureshi","year":"2021","journal-title":"J\u00a0Pediatr Urol"},{"issue":"9","key":"10.1016\/j.suc.2022.07.006_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.29173","article-title":"Role of anticoagulation in the management of tumor thrombus: A 10-year single-center experience","volume":"68","author":"Agarwal","year":"2021","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"10.1016\/j.suc.2022.07.006_bib13","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jpedsurg.2018.09.005","article-title":"Update on Wilms tumor","volume":"54","author":"Aldrink","year":"2019","journal-title":"J\u00a0Pediatr Surg"},{"issue":"3","key":"10.1016\/j.suc.2022.07.006_bib14","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1399-3046.2005.00311.x","article-title":"Outcome of renal transplantation for Wilms\u2019 tumor and Denys-Drash syndrome: a report of the North American Pediatric Renal Transplant Cooperative Study","volume":"9","author":"Kist-Van Holthe","year":"2005","journal-title":"Pediatr Transpl"},{"issue":"1","key":"10.1016\/j.suc.2022.07.006_bib15","doi-asserted-by":"crossref","first-page":"6","DOI":"10.4103\/0971-9261.54811","article-title":"Management of Wilms\u2019 tumor: NWTS vs SIOP","volume":"14","author":"Bhatnagar","year":"2009","journal-title":"J\u00a0Indian Assoc Pediatr Surg"},{"issue":"4","key":"10.1016\/j.suc.2022.07.006_bib16","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/s41581-019-0112-0","article-title":"The genetic changes of Wilms tumour","volume":"15","author":"Treger","year":"2019","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"10.1016\/j.suc.2022.07.006_bib17","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.ijrobp.2018.01.110","article-title":"Timing of radiation therapy in pediatric wilms tumor: a report from the national cancer database","volume":"101","author":"Stokes","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"S2","key":"10.1016\/j.suc.2022.07.006_bib18","doi-asserted-by":"crossref","first-page":"e28257","DOI":"10.1002\/pbc.28257","article-title":"Wilms tumor","volume":"68","author":"Pater","year":"2021","journal-title":"Pediatr Blood Cancer"},{"issue":"10","key":"10.1016\/j.suc.2022.07.006_bib19","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1002\/pbc.24604","article-title":"Incidence and outcomes of patients with late recurrence of Wilms\u2019 tumor","volume":"60","author":"Malogolowkin","year":"2013","journal-title":"Pediatr Blood Cancer"},{"issue":"12","key":"10.1016\/j.suc.2022.07.006_bib20","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1136\/adc.2006.101295","article-title":"Surveillance for Wilms tumour in at-risk children: pragmatic recommendations for best practice","volume":"91","author":"Scott","year":"2006","journal-title":"Arch Dis Child"},{"issue":"5","key":"10.1016\/j.suc.2022.07.006_bib21","first-page":"1972","article-title":"End stage renal disease in patients with Wilms tumor: results from the National Wilms Tumor Study Group and the United States Renal Data System","volume":"174","author":"Breslow","year":"2005","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.suc.2022.07.006_bib22","doi-asserted-by":"crossref","DOI":"10.12659\/MSM.927218","article-title":"Comparison of incidence and outcomes of neuroblastoma in children, adolescents, and adults in the United States: a surveillance, epidemiology, and end results (SEER) Program Population Study","volume":"26","author":"Yan","year":"2020","journal-title":"Med Sci Monit"},{"issue":"4","key":"10.1016\/j.suc.2022.07.006_bib23","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/pbc.24777","article-title":"Neuroblastoma in older children, adolescents and young adults: a report from the International Neuroblastoma Risk Group project","volume":"61","author":"Moss\u00e9","year":"2014","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"10.1016\/j.suc.2022.07.006_bib24","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1200\/JCO.2001.19.4.1047","article-title":"Treatment and outcome of 83 children with intraspinal neuroblastoma: the Pediatric Oncology Group experience","volume":"19","author":"Katzenstein","year":"2001","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.suc.2022.07.006_bib25","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/pbc.23186","article-title":"A\u00a0sequential treatment algorithm for infants with stage 4s neuroblastoma and massive hepatomegaly","volume":"59","author":"Weintraub","year":"2012","journal-title":"Pediatr Blood Cancer"},{"issue":"29","key":"10.1016\/j.suc.2022.07.006_bib26","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1200\/JCO.21.00278","article-title":"Revised Neuroblastoma Risk Classification System: A Report From the Children\u2019s Oncology Group","volume":"39","author":"Irwin","year":"2021","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.suc.2022.07.006_bib27","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/SLA.0b013e31826cbbbd","article-title":"A\u00a0prospective study of expectant observation as primary therapy for neuroblastoma in young infants: a Children\u2019s Oncology Group study","volume":"256","author":"Nuchtern","year":"2012","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.suc.2022.07.006_bib29","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1200\/JCO.2000.18.1.18","article-title":"Biologic variables in the outcome of stages I and II neuroblastoma treated with surgery as primary therapy: a children\u2019s cancer group study","volume":"18","author":"Perez","year":"2000","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.suc.2022.07.006_bib30","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1080\/14737140.2017.1285230","article-title":"Overview and recent advances in the treatment of neuroblastoma","volume":"17","author":"Whittle","year":"2017","journal-title":"Expert Rev Anticancer Ther"},{"issue":"10","key":"10.1016\/j.suc.2022.07.006_bib31","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1007\/s00259-020-04741-x","article-title":"A\u00a0phase IIa trial of molecular radiotherapy with 177-lutetium DOTATATE in children with primary refractory or relapsed high-risk neuroblastoma","volume":"47","author":"Gains","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"16","key":"10.1016\/j.suc.2022.07.006_bib32","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1056\/NEJM199910143411601","article-title":"Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children\u2019s Cancer Group","volume":"341","author":"Atherine","year":"1999","journal-title":"N\u00a0Engl J Med"},{"issue":"24","key":"10.1016\/j.suc.2022.07.006_bib33","doi-asserted-by":"crossref","first-page":"4914","DOI":"10.1002\/cncr.30934","article-title":"Historical time to disease progression and progression-free survival in patients with recurrent\/refractory neuroblastoma treated in the modern era on Children\u2019s Oncology Group early-phase trials","volume":"123","author":"London","year":"2017","journal-title":"Cancer"},{"issue":"16","key":"10.1016\/j.suc.2022.07.006_bib34","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1093\/jnci\/djp230","article-title":"Long-term outcomes in survivors of neuroblastoma: a report from the Childhood Cancer Survivor Study","volume":"101","author":"Laverdi\u00e9re","year":"2009","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"4","key":"10.1016\/j.suc.2022.07.006_bib35","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0094-0143(03)00053-3","article-title":"Neuroblastoma: management, recurrence, and follow-up","volume":"30","author":"Lee","year":"2003","journal-title":"Urol Clin North Am"},{"issue":"4","key":"10.1016\/j.suc.2022.07.006_bib36","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00043426-200105000-00008","article-title":"Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: a selective review of intergroup rhabdomyosarcoma study group experience and rationale for Intergroup Rhabdomyosarcoma Study V","volume":"23","author":"Beverly Raney","year":"2001","journal-title":"J\u00a0Pediatr Hematol Oncol"},{"issue":"10","key":"10.1016\/j.suc.2022.07.006_bib37","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1016\/j.jpedsurg.2020.06.015","article-title":"Update on pediatric rhabdomyosarcoma: A report from the APSA Cancer Committee","volume":"55","author":"Rhee","year":"2020","journal-title":"J\u00a0Pediatr Surg"},{"issue":"5","key":"10.1016\/j.suc.2022.07.006_bib39","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1007\/BF01655884","article-title":"Surgical lessons from the Intergroup Rhabdomyosarcoma Study (IRS) pertaining to extremity tumors","volume":"12","author":"Lawrence","year":"1988","journal-title":"World J Surg"},{"issue":"7","key":"10.1016\/j.suc.2022.07.006_bib40","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1007\/s003830100580","article-title":"Primary re-excision: The Italian experience in patients with localized soft-tissue sarcomas","volume":"17","author":"Cecchetto","year":"2001","journal-title":"Pediatr Surg Int"},{"issue":"2","key":"10.1016\/j.suc.2022.07.006_bib41","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/cncr.33275","article-title":"Benefit of delayed primary excision in rhabdomyosarcoma: A report from the Children\u2019s Oncology Group","volume":"127","author":"Lautz","year":"2021","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.suc.2022.07.006_bib42","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jpedsurg.2016.08.024","article-title":"Quality assessment of lymph node sampling in rhabdomyosarcoma: A surveillance, epidemiology, and end results (SEER) program study","volume":"52","author":"Lobeck","year":"2017","journal-title":"J\u00a0Pediatr Surg"},{"issue":"11","key":"10.1016\/j.suc.2022.07.006_bib43","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1002\/ijc.33143","article-title":"Impact of local control and surgical lymph node evaluation in localized paratesticular rhabdomyosarcoma: A report from the Children\u2019s Oncology Group Soft-tissue Sarcoma Committee","volume":"147","author":"Routh","year":"2020","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.suc.2022.07.006_bib44","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ijrobp.2018.08.017","article-title":"Treatment Approach and Outcomes in Infants With Localized Rhabdomyosarcoma: A Report From the Soft-tissue Sarcoma Committee of the Children\u2019s Oncology Group","volume":"103","author":"Bradley","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.suc.2022.07.006_bib45","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ijrobp.2010.01.058","article-title":"Influence of noncompliance with radiation therapy protocol guidelines and operative bed recurrences for children with rhabdomyosarcoma and microscopic residual disease: a report from the Children\u2019s Oncology Group","volume":"80","author":"Million","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.suc.2022.07.006_bib46","first-page":"7","article-title":"Cancer Statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"26","key":"10.1016\/j.suc.2022.07.006_bib47","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1200\/JCO.20.03060","article-title":"Genomic Classification and Clinical Outcome in Rhabdomyosarcoma: A Report From an International Consortium","volume":"39","author":"Shern","year":"2021","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.suc.2022.07.006_bib48","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/cncr.32603","article-title":"Is surveillance imaging in pediatric patients treated for localized rhabdomyosarcoma useful? The European experience","volume":"126","author":"Vaarwerk","year":"2020","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.suc.2022.07.006_bib49","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1093\/jnci\/djaa204","article-title":"Germline Cancer Predisposition Variants in Pediatric Rhabdomyosarcoma: A Report From the Children\u2019s Oncology Group","volume":"113","author":"Li","year":"2021","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"11","key":"10.1016\/j.suc.2022.07.006_bib50","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1002\/cncr.29265","article-title":"Predictors of colorectal cancer surveillance among radiation-treated survivors of childhood cancer: a report from the childhood cancer survivor study","volume":"121","author":"Daniel","year":"2015","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.suc.2022.07.006_bib51","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1200\/JCO.1992.10.4.614","article-title":"Late effects of therapy in patients with paratesticular rhabdomyosarcoma. Intergroup Rhabdomyosarcoma Study Committee","volume":"10","author":"Heyn","year":"1992","journal-title":"J\u00a0Clin Oncol"},{"issue":"3 Pt 2","key":"10.1016\/j.suc.2022.07.006_bib52","first-page":"435","article-title":"Long-term follow-up and complications of infants with vulvovaginal embryonal rhabdomyosarcoma treated with surgery, radiation therapy, and chemotherapy","volume":"71","author":"Piver","year":"1988","journal-title":"Obstet Gynecol"},{"issue":"15","key":"10.1016\/j.suc.2022.07.006_bib53","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1002\/cncr.28733","article-title":"Long-term cause-specific mortality in survivors of adolescent and young adult bone and soft-tissue sarcoma: A population-based study of 28,844 patients","volume":"120","author":"Youn","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.suc.2022.07.006_bib54","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.radonc.2018.10.036","article-title":"AMORE treatment as salvage treatment in children and young adults with relapsed head-neck rhabdomyosarcoma","volume":"131","author":"Vaarwerk","year":"2019","journal-title":"Radiother Oncol"},{"issue":"4","key":"10.1016\/j.suc.2022.07.006_bib55","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.oooo.2018.12.012","article-title":"Dental and craniofacial alterations in long-term survivors of childhood head and neck rhabdomyosarcoma","volume":"127","author":"Mattos","year":"2019","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"10","key":"10.1016\/j.suc.2022.07.006_bib56","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26508","article-title":"Facial asymmetry in head and neck rhabdomyosarcoma survivors","volume":"64","author":"Schoot","year":"2017","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"10.1016\/j.suc.2022.07.006_bib57","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1053\/jhep.2003.50375","article-title":"Epidemiology of primary hepatic malignancies in U.S. children","volume":"38","author":"Darbari","year":"2003","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.suc.2022.07.006_bib58","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/MOP.0000000000000081","article-title":"Management of hepatoblastoma: an update","volume":"26","author":"Kremer","year":"2014","journal-title":"Curr Opin Pediatr"},{"issue":"4","key":"10.1016\/j.suc.2022.07.006_bib59","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s00247-018-4078-z","article-title":"2017 PRETEXT: radiologic staging system for primary hepatic malignancies of childhood revised for the Paediatric Hepatic International Tumour Trial (PHITT)","volume":"48","author":"Towbin","year":"2018","journal-title":"Pediatr Radiol"},{"issue":"6","key":"10.1016\/j.suc.2022.07.006_bib60","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/MPG.0b013e3181dcd277","article-title":"Hepatoblastoma with tumor extension through the inferior vena cava into the right atrium","volume":"50","author":"Huang","year":"2010","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"issue":"7","key":"10.1016\/j.suc.2022.07.006_bib61","doi-asserted-by":"crossref","DOI":"10.1111\/petr.13948","article-title":"The extracorporeal circulation with transdiaphragmatic approach in living-donor liver transplantation for HB with atrial extension of tumor thrombus: A case report","volume":"25","author":"Shimizu","year":"2021","journal-title":"Pediatr Transpl"},{"issue":"2","key":"10.1016\/j.suc.2022.07.006_bib62","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.soc.2020.11.006","article-title":"Liver tumors in pediatric patients","volume":"30","author":"Meyers","year":"2021","journal-title":"Surg Oncol Clin N Am"},{"issue":"6","key":"10.1016\/j.suc.2022.07.006_bib64","doi-asserted-by":"crossref","first-page":"e165","DOI":"10.1097\/TXD.0000000000000685","article-title":"Hepatoblastoma: transplant versus resection experience in a latin american transplant center","volume":"3","author":"Caicedo","year":"2017","journal-title":"Transpl Direct"},{"issue":"4","key":"10.1016\/j.suc.2022.07.006_bib65","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/petr.12699","article-title":"Effects of an early referral system on liver transplantation for hepatoblastoma at Texas Children\u2019s Hospital","volume":"20","author":"Kueht","year":"2016","journal-title":"Pediatr Transpl"},{"issue":"12","key":"10.1016\/j.suc.2022.07.006_bib66","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11121944","article-title":"Surgical management of hepatoblastoma and recent advances","volume":"11","author":"Yang","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"8","key":"10.1016\/j.suc.2022.07.006_bib67","doi-asserted-by":"crossref","first-page":"e27103","DOI":"10.1002\/pbc.27103","article-title":"Hepatoblastoma in patients with molecularly proven familial adenomatous polyposis: Clinical characteristics and rationale for surveillance screening","volume":"65","author":"Trobaugh-Lotrario","year":"2018","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"10.1016\/j.suc.2022.07.006_bib68","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1055\/s-0038-1668148","article-title":"Prognostic Factors for Liver Transplantation in Unresectable Hepatoblastoma","volume":"29","author":"Triana Junco","year":"2019","journal-title":"Eur J Pediatr Surg"},{"issue":"2","key":"10.1016\/j.suc.2022.07.006_bib69","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.surg.2012.11.006","article-title":"Analysis of national and single-center incidence and survival after liver transplantation for hepatoblastoma: new trends and future opportunities","volume":"153","author":"Cruz","year":"2013","journal-title":"Surgery"},{"issue":"6","key":"10.1016\/j.suc.2022.07.006_bib70","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1053\/j.sempedsurg.2014.06.005","article-title":"Epidemiology of adhesions in infants and children following open surgery","volume":"23","author":"Lakshminarayanan","year":"2014","journal-title":"Semin Pediatr Surg"},{"issue":"3","key":"10.1016\/j.suc.2022.07.006_bib71","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/bjs.10072","article-title":"Adhesive small bowel obstruction after laparotomy during infancy","volume":"103","author":"Fredriksson","year":"2016","journal-title":"Br J Surg"},{"issue":"1","key":"10.1016\/j.suc.2022.07.006_bib72","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.pcl.2018.09.008","article-title":"Long-term outcomes of kidney transplantation in children","volume":"66","author":"Winterberg","year":"2019","journal-title":"Pediatr Clin North America"},{"issue":"1","key":"10.1016\/j.suc.2022.07.006_bib73","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ejmg.2016.09.014","article-title":"Mycophenolate mofetil embryopathy: A newly recognized teratogenic syndrome","volume":"60","author":"Perez-Aytes","year":"2017","journal-title":"Eur J Med Genet"},{"issue":"26","key":"10.1016\/j.suc.2022.07.006_bib74","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1056\/NEJMoa031643","article-title":"Long-term survival of children with end-stage renal disease","volume":"350","author":"McDonald","year":"2004","journal-title":"New Engl J Med"},{"key":"10.1016\/j.suc.2022.07.006_bib75","doi-asserted-by":"crossref","first-page":"100987","DOI":"10.1016\/j.eclinm.2021.100987","article-title":"Outcomes of adults who received liver transplant as young children","volume":"38","author":"Vimalesvaran","year":"2021","journal-title":"EClinicalMedicine"},{"issue":"2","key":"10.1016\/j.suc.2022.07.006_bib76","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/lt.24677","article-title":"Immunosuppression in pediatric liver transplant recipients: Unique aspects","volume":"23","author":"Miloh","year":"2017","journal-title":"Liver Transplant"},{"issue":"5","key":"10.1016\/j.suc.2022.07.006_bib77","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1002\/hep.31520","article-title":"Efficacy and safety of immunosuppression withdrawal in pediatric liver transplant recipients: moving toward personalized management","volume":"73","author":"Feng","year":"2021","journal-title":"Hepatology"},{"issue":"17","key":"10.1016\/j.suc.2022.07.006_bib78","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1161\/CIR.0b013e3182a88099","article-title":"Long-term cardiovascular toxicity in children, adolescents, and young adults who receive cancer therapy: pathophysiology, course, monitoring, management, prevention, and research directions: a scientific statement from the American Heart Association","volume":"128","author":"Lipshultz","year":"2013","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.suc.2022.07.006_bib79","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/CAD.0b013e32803d36fe","article-title":"Long-term follow-up of patients with doxorubicin-induced cardiac toxicity after chemotherapy for osteosarcoma","volume":"18","author":"Longhi","year":"2007","journal-title":"Anti-Cancer Drugs"},{"issue":"3","key":"10.1016\/j.suc.2022.07.006_bib80","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1016\/S1470-2045(14)70409-7","article-title":"Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: A report from the International Late Effects of Childhood Cancer Guideline Harmonization Group","volume":"16","author":"Armenian","year":"2015","journal-title":"The Lancet Oncol"},{"issue":"3","key":"10.1016\/j.suc.2022.07.006_bib81","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/j.2040-4603.2019.tb00082.x","article-title":"Doxorubicin-induced cardiomyopathy in children","volume":"9","author":"Mancilla","year":"2019","journal-title":"Compr Physiol"},{"issue":"4","key":"10.1016\/j.suc.2022.07.006_bib82","doi-asserted-by":"crossref","first-page":"647","DOI":"10.2217\/fca.12.44","article-title":"Cardiotoxicity in childhood cancer survivors: Strategies for prevention and management","volume":"8","author":"Harake","year":"2012","journal-title":"Future Cardiol"},{"issue":"2","key":"10.1016\/j.suc.2022.07.006_bib83","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/pbc.22882","article-title":"Dactinomycin and vincristine toxicity in the treatment of childhood cancer: a retrospective study from the Children\u2019s Oncology Group","volume":"57","author":"Langholz","year":"2011","journal-title":"Pediatr Blood Cancer"},{"issue":"9","key":"10.1016\/j.suc.2022.07.006_bib84","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1200\/JCO.1990.8.9.1525","article-title":"Severe hepatic toxicity after treatment with vincristine and dactinomycin using single-dose or divided-dose schedules: a report from the National Wilms\u2019 Tumor Study","volume":"8","author":"DM G","year":"1990","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.suc.2022.07.006_bib85","first-page":"208","article-title":"Long-term complications following childhood and adolescent cancer: foundations for providing risk-based health care for survivors","volume":"54","author":"Oeffinger","year":"2004","journal-title":"CA: A Cancer J Clinicians"},{"issue":"8","key":"10.1016\/j.suc.2022.07.006_bib86","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1093\/humrep\/dey229","article-title":"Long-term effects of childhood cancer treatment on hormonal and ultrasound markers of ovarian reserve","volume":"33","author":"van den Berg","year":"2018","journal-title":"Hum Reprod"},{"issue":"8","key":"10.1016\/j.suc.2022.07.006_bib87","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1080\/14737140.2017.1335199","article-title":"Anticancer treatments and female fertility: clinical concerns and role of oncologists in oncofertility practice","volume":"17","author":"Salama","year":"2017","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.suc.2022.07.006_bib88","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.710163","article-title":"Long-term effects of pediatric acute lymphoblastic leukemia chemotherapy: can recent findings inform old strategies?","volume":"11","author":"Al-Mahayri","year":"2021","journal-title":"Front Oncol"},{"issue":"11","key":"10.1016\/j.suc.2022.07.006_bib89","first-page":"2416","article-title":"Vincristine-induced peripheral neuropathy in pediatric cancer patients","volume":"6","author":"Mora","year":"2016","journal-title":"Am J Cancer Res"},{"issue":"8","key":"10.1016\/j.suc.2022.07.006_bib90","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.apmr.2013.03.009","article-title":"Chemotherapy-related neuropathic symptoms and functional impairment in adult survivors of extracranial solid tumors of childhood: results from the St. Jude Lifetime Cohort Study","volume":"94","author":"Ness","year":"2013","journal-title":"Arch Phys Med Rehabil"},{"issue":"5","key":"10.1016\/j.suc.2022.07.006_bib91","doi-asserted-by":"crossref","DOI":"10.1097\/NCC.0b013e318299ad23","article-title":"Measuring vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia","volume":"36","author":"Smith","year":"2013","journal-title":"Cancer Nurs"},{"issue":"8","key":"10.1016\/j.suc.2022.07.006_bib92","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1001\/jamaneurol.2018.0963","article-title":"Chemotherapy-induced peripheral neuropathy in long-term survivors of childhood cancer clinical, neurophysiological, functional, and patient-reported outcomes","volume":"75","author":"Kandula","year":"2018","journal-title":"JAMA Neurol"},{"issue":"49","key":"10.1016\/j.suc.2022.07.006_bib93","doi-asserted-by":"crossref","first-page":"e23173","DOI":"10.1097\/MD.0000000000023173","article-title":"Long term complications and prognostic factors in locally advanced nasopharyngeal carcinoma treated with docetaxel, cisplatin, 5-fluorouracil induction chemotherapy followed by concurrent chemoradiotherapy: A retrospective cohort study","volume":"99","author":"Shim","year":"2020","journal-title":"Medicine"},{"issue":"2","key":"10.1016\/j.suc.2022.07.006_bib94","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00467-017-3662-z","article-title":"Late renal toxicity of treatment for childhood malignancy: risk factors, long-term outcomes, and surveillance","volume":"33","author":"Skinner","year":"2018","journal-title":"Pediatr Nephrol"},{"issue":"12","key":"10.1016\/j.suc.2022.07.006_bib95","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1038\/sj.bjc.6605095","article-title":"Evaluation of sub-acute changes in cardiac function after cisplatin-based combination chemotherapy for testicular cancer","volume":"100","author":"Altena","year":"2009","journal-title":"Br J Cancer"},{"issue":"11","key":"10.1016\/j.suc.2022.07.006_bib96","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1093\/annonc\/mdx360","article-title":"Long-term toxicity of cisplatin in germ-cell tumor survivors","volume":"28","author":"Chovanec","year":"2017","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.suc.2022.07.006_bib97","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/ehjci\/jeaa289","article-title":"The cardiac impact of cisplatin-based chemotherapy in survivors of testicular cancer: a 30-year follow-up","volume":"22","author":"Bjerring","year":"2021","journal-title":"Eur Heart J - Cardiovasc Imaging"},{"issue":"1 Suppl","key":"10.1016\/j.suc.2022.07.006_bib98","article-title":"Pharmacodynamics and long-term toxicity of etoposide","volume":"34","author":"Kobayashi","year":"1994","journal-title":"Cancer Chemother Pharmacol"},{"issue":"1","key":"10.1016\/j.suc.2022.07.006_bib99","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.spen.2016.12.005","article-title":"Neurological Complications of Childhood Cancer","volume":"24","author":"Weaver","year":"2017","journal-title":"Semin Pediatr Neurol"},{"issue":"12","key":"10.1016\/j.suc.2022.07.006_bib100","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/S1470-2045(18)30537-0","article-title":"Temporal patterns in the risk of chronic health conditions in survivors of childhood cancer diagnosed 1970\u201399: a report from the Childhood Cancer Survivor Study cohort","volume":"19","author":"Gibson","year":"2018","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.suc.2022.07.006_bib101","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1053\/j.ackd.2021.10.007","article-title":"Chronic Kidney Disease in Cancer Survivors","volume":"28","author":"Lee","year":"2021","journal-title":"Adv Chronic Kidney Dis"},{"issue":"5","key":"10.1016\/j.suc.2022.07.006_bib102","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1097\/AOG.0b013e3181f87c4b","article-title":"Reproductive outcomes for survivors of childhood cancer","volume":"116","author":"Hudson","year":"2010","journal-title":"Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.suc.2022.07.006_bib103","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1007\/s10147-018-1303-6","article-title":"Secondary cancer after a childhood cancer diagnosis: viewpoints considering primary cancer","volume":"23","author":"Ishida","year":"2018","journal-title":"Int J Clin Oncol"},{"issue":"3","key":"10.1016\/j.suc.2022.07.006_bib104","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2007-1396","article-title":"Bone mineral density deficits in survivors of childhood cancer: Long-term foIIow-up guidelines and review of the literature","volume":"121","author":"Wasilewski-Masker","year":"2008","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.suc.2022.07.006_bib105","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1667\/RR14888.1","article-title":"Hypothyroidism following radiation therapy for childhood cancer: a report from the childhood cancer survivor study","volume":"190","author":"Inskip","year":"2018","journal-title":"Radiat Res"},{"issue":"8","key":"10.1016\/j.suc.2022.07.006_bib106","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1210\/jc.2018-01175","article-title":"Hypothalamic-pituitary and growth disorders in survivors of childhood cancer: An Endocrine Society Clinical Practice Guideline","volume":"103","author":"Sklar","year":"2018","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.suc.2022.07.006_bib107","doi-asserted-by":"crossref","first-page":"6100","DOI":"10.1210\/jc.2004-1515","article-title":"Growth hormone therapy in children after cranial\/craniospinal radiation therapy: sexually dimorphic outcomes","volume":"89","author":"Lerner","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.suc.2022.07.006_bib108","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/mpo.2950210909","article-title":"Avascular femoral head necrosis in pediatric cancer patients","volume":"21","author":"Hanif","year":"1993","journal-title":"Med Pediatr Oncol"},{"issue":"10","key":"10.1016\/j.suc.2022.07.006_bib109","doi-asserted-by":"crossref","DOI":"10.3928\/01477447-20110826-07","article-title":"Avascular necrosis of the femoral head in children with acute lymphoblastic leukemia: A 4- to 9-year follow-up study","volume":"34","author":"Madadi","year":"2011","journal-title":"Orthopedics"},{"issue":"12","key":"10.1016\/j.suc.2022.07.006_bib110","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1200\/JCO.2005.05.0096","article-title":"Sensorineural hearing loss after radiotherapy and chemoradiotherapy: A single, blinded, randomized study","volume":"24","author":"Wong","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"issue":"12","key":"10.1016\/j.suc.2022.07.006_bib111","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0209193","article-title":"Late vertebral side effects in long-term survivors of irradiated childhood brain tumor","volume":"13","author":"Jussila","year":"2018","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.suc.2022.07.006_bib112","first-page":"1","article-title":"Promotion of arterial stiffness by childhood cancer and its characteristics in adult long-term survivors","volume":"10","author":"Arnold","year":"2021","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"6","key":"10.1016\/j.suc.2022.07.006_bib113","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3109\/08880010903019344","article-title":"Late effects of treatment for wilms tumor","volume":"26","author":"Wright","year":"2009","journal-title":"Pediatric hematology oncology journal"},{"issue":"15","key":"10.1016\/j.suc.2022.07.006_bib114","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1200\/JCO.2015.64.4344","article-title":"Risk of adverse health and social outcomes up to 50 years after wilms tumor: The British childhood cancer survivor study","volume":"34","author":"Wong","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"issue":"14","key":"10.1016\/j.suc.2022.07.006_bib115","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1093\/jnci\/djq238","article-title":"Subsequent neoplasms in 5-year survivors of childhood cancer: the childhood cancer survivor study","volume":"102","author":"Friedman","year":"2010","journal-title":"JNCI J Natl Cancer Inst"},{"issue":"22","key":"10.1016\/j.suc.2022.07.006_bib116","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1001\/jama.2011.747","article-title":"Long-term risks of subsequent primary neoplasms among survivors of childhood cancer","volume":"305","author":"Reulen","year":"2011","journal-title":"JAMA - J Am Med Assoc"},{"issue":"11","key":"10.1016\/j.suc.2022.07.006_bib117","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1002\/cncr.29265","article-title":"Predictors of colorectal cancer surveillance among survivors of childhood cancer treated with radiation: A report from the Childhood Cancer Survivor Study","volume":"121","author":"Daniel","year":"2015","journal-title":"Cancer"},{"issue":"21","key":"10.1016\/j.suc.2022.07.006_bib118","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1200\/JCO.2017.76.5552","article-title":"Psychological symptoms, social outcomes, socioeconomic attainment, and health behaviors among survivors of childhood cancer: Current state of the literature","volume":"36","author":"Brinkman","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"issue":"24","key":"10.1016\/j.suc.2022.07.006_bib119","doi-asserted-by":"crossref","first-page":"3873","DOI":"10.1002\/cncr.30253","article-title":"Economic independence in survivors of cancer diagnosed at a young age: A Norwegian national cohort study","volume":"122","author":"Gunnes","year":"2016","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.suc.2022.07.006_bib120","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s11764-019-00822-5","article-title":"Posttraumatic stress as a contributor to behavioral health outcomes and health care utilization in adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study","volume":"13","author":"Crochet","year":"2019","journal-title":"J\u00a0Cancer Survivorship"},{"issue":"12","key":"10.1016\/j.suc.2022.07.006_bib121","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1002\/cncr.32853","article-title":"Longitudinal pain and pain interference in long-term survivors of childhood cancer: A report from the Childhood Cancer Survivor Study","volume":"126","author":"Karlson","year":"2020","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.suc.2022.07.006_bib122","first-page":"S111","article-title":"Prescription opioid abuse in chronic pain: an updated review of opioid abuse predictors and strategies to curb opioid abuse (Part 2)","volume":"20","author":"Kaye","year":"2017","journal-title":"Pain Physician"},{"key":"10.1016\/j.suc.2022.07.006_bib123","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jpeds.2017.11.063","article-title":"Early Post-Therapy Prescription Drug Usage among Childhood and Adolescent Cancer Survivors","volume":"195","author":"Smitherman","year":"2018","journal-title":"J\u00a0Pediatr"},{"issue":"9","key":"10.1016\/j.suc.2022.07.006_bib124","article-title":"Management of patients with chronic pain in ambulatory surgery Centers","volume":"12","author":"Charipova","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.suc.2022.07.006_bib125","doi-asserted-by":"crossref","DOI":"10.1016\/j.canep.2020.101779","article-title":"Subsequent neoplasms in childhood cancer survivors","volume":"68","author":"Zichov\u00e1","year":"2020","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.suc.2022.07.006_bib127","doi-asserted-by":"crossref","DOI":"10.1016\/j.canep.2020.101733","article-title":"Childhood cancer: Survival, treatment modalities, late effects and improvements over time","volume":"71","author":"Erdmann","year":"2021","journal-title":"Cancer Epidemiol"},{"issue":"9","key":"10.1016\/j.suc.2022.07.006_bib128","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1002\/ijc.23333","article-title":"Second primary neoplasms in survivors of Wilms\u2019 tumour - A population-based cohort study from the British Childhood Cancer Survivor Study","volume":"122","author":"Taylor","year":"2008","journal-title":"Int J Cancer"}],"container-title":["Surgical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039610922000743?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039610922000743?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T11:13:45Z","timestamp":1758539625000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039610922000743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":123,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S0039610922000743"],"URL":"https:\/\/doi.org\/10.1016\/j.suc.2022.07.006","relation":{},"ISSN":["0039-6109"],"issn-type":[{"value":"0039-6109","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Abdominal Tumors","name":"articletitle","label":"Article Title"},{"value":"Surgical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.suc.2022.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}